
Podcast
Too Little, Too Much: How Much Sleep is Just Right? - Frankly Speaking EP 55
In this session we discuss the impact of length of sleep on obesity and DM II.
Episode references and resource links:
- Bioulac, S, Micoulaud Franchi, JA, Arnaud, M, Sagaspe, P, Moore, N, Salvo, F, Philip, P; Risk of Motor Vehicle Accidents Related to Sleepiness at the Wheel: A Systematic Review and Meta-Analysis, Sleep, Volume 40, Issue 10, 1 October 2017, zsx134, https://doi.org/10.1093/sleep/zsx134; https://academic.oup.com/sleep/article/40/10/zsx134/4049536
- FernandezāMendoza J, He F, LaGrotte C, Vgontzas AN, Liao D, Bixler EO. Impact of the Metabolic Syndrome on Mortality is Modified by Objective Short Sleep Duration. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease. 2017;6(5):e005479. doi:10.1161/JAHA.117.005479, https://www.ncbi.nlm.nih.gov/pubmed/28515112
- Han-Bing Deng, Tony Tam, Benny Chung-Ying Zee, Roger Yat-Nork Chung, Xuefen Su, Lei Jin, Ta-Chien Chan, Ly-Yun Chang, Eng-Kiong Yeoh, Xiang Qian Lao; Short Sleep Duration Increases Metabolic Impact in Healthy Adults: A Population-Based Cohort Study, Sleep, Volume 40, Issue 10, 1 October 2017, zsx130, https://www.ncbi.nlm.nih.gov/pubmed/28977563
- Tan, Xiao et al. Association between long sleep duration and increased risk of obesity and type 2 diabetes: A review of possible mechanisms, Sleep Medicine Reviews, Volume 0 , Issue 0, http://bs7xv3ec2w.search.serialssolutions.com/?sid=Entrez:PubMed&id=pmid:29233612
Already listened on another platform?
CME/CE Information
0 Credits - Not for CME/CE Credit
Release Date: 2/12/2018
Expiration Date: 2/12/2020
Topics
Faculty

Frank J. Domino, MD
Professor, Family Medicine and Community Health,
University of Massachusetts Medical School, Worcester, MA

Susan Feeney, DNP, FNP, FAANP
Assistant Professor and Coordinator of the Family Nurse Practitioner Track
UMMS GSN
Disclosures
The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute.
Frank J. Domino, MD: Has disclosed no relevant financial relationships.
Susan Feeney, DNP, FNP-BC, NP-C: Has disclosed no relevant financial relationships.
Non-faculty contributors involved in the planning, development, editing, and review of the content have disclosed no relevant financial relationships.
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients. Data, indications, and guidelines presented in this activity are current as of the activity release date and they are subject to change as new information is published.
Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.
Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. Pri-Med Institute is the accredited provider for this activity.
Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation.
Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.
Questions?
If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.